Amador Bioscience
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $60M
Investors
- 5
About Amador Bioscience
Amador Bioscience, Inc.Founded in 2018 and headquartered in Pleasanton, California, Amador Bioscience, Inc. specializes in clinical pharmacology and bioanalytical services. The company has engaged in a total of 2 deals since inception, aiming to strengthen its clinical capabilities and expand its service offerings globally.Amador Bioscience specializes in integrating clinical pharmacology, bioanalysis, and clinical research, providing comprehensive solutions tailored for the pharmaceutical and biotechnology sectors. The company's core product offerings encompass a range of services designed to support drug development processes, including bioanalytical testing, pharmacokinetic studies, and clinical trial management. These services aim to enhance the efficiency and effectiveness of drug development for clients focused on bringing new therapeutics to market. The firm addresses critical challenges faced by its diverse clientele, including pharmaceutical companies, biotech firms, and academic institutions.Amador Bioscience generates revenue through its suite of specialized services aimed at the life sciences sector, operating primarily on a business-to-business model. The company engages in various transaction structures, including service contracts with pharmaceutical and biotech firms, structured as project-based agreements or ongoing partnerships. This transactional framework allows clients to leverage Amador Bioscience's capabilities for specific phases of their product development lifecycle. Pricing plans are determined based on the complexity and scope of the projects undertaken, ensuring tailored solutions that meet unique research needs.In December 2021, Amador Bioscience, Inc. The company aims to introduce new products designed to enhance its service offerings in the coming years. Additionally, there are plans to expand into new markets, specifically targeting growth opportunities in Europe and Asia by 2024.
Who invested in Amador Bioscience
5 investors across 2 rounds
See all investors in Amador Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Amador Bioscience
Who invested in Amador Bioscience?
Amador Bioscience has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amador Bioscience raised?
Amador Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Amador Bioscience last raise money?
Amador Bioscience's most recent round on record is a Series B, in Dec 2021.
What does Amador Bioscience do?
Amador Bioscience is a biotechnology company.
Where is Amador Bioscience headquartered?
Amador Bioscience is headquartered in Pleasanton, US.
Which VCs invest in companies like Amador Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Amador Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Amador Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.